Loading…

COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know

Saved in:

Bibliographic Details
Published in:	Journal of molecular and cellular cardiology 2020-07, Vol.144, p.12-14
Main Authors:	Dhawan, Rahul, Gundry, Rebekah L., Brett-Major, David M., Mahr, Claudius, Thiele, Geoffrey M., Lindsey, Merry L., Anderson, Daniel R.
Format:	Article
Language:	English
Subjects:	ACE Angiotensin converting enzyme inhibitors Angiotensin converting enzyme receptor 2 Angiotensin Receptor Antagonists - adverse effects Angiotensin Receptor Antagonists - pharmacology Angiotensin-Converting Enzyme 2 Angiotensin-Converting Enzyme Inhibitors - adverse effects Angiotensin-Converting Enzyme Inhibitors - pharmacology Animals Betacoronavirus - pathogenicity Cardiovascular disease Cardiovascular Diseases - complications Cardiovascular Diseases - drug therapy Cardiovascular Diseases - physiopathology Coronavirus Coronavirus Infections - drug therapy Coronavirus Infections - etiology COVID-19 Host-Pathogen Interactions - physiology Humans Pandemics Peptidyl-Dipeptidase A - metabolism Pneumonia, Viral - drug therapy Pneumonia, Viral - etiology Renin angiotensin system SARS-CoV-2 Serine Endopeptidases - metabolism Serine Proteinase Inhibitors - pharmacology
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!